Polyunsaturated fatty acid.

Every double bond in a polyunsaturated chain is a site where oxidation can start, and the bis-allylic carbons between them are the weakest points. Alpha-tocopherol sits in the membrane and quenches the propagating lipid radical, breaking the chain reaction. This is why PUFA supplements are formulated with tocopherol and why raising PUFA intake raises vitamin E requirement.

Astaxanthin spans the membrane bilayer rather than sitting within one leaflet, which lets it intercept radicals at both surfaces. It is used alongside PUFA oils for oxidative protection, and krill oil carries it natively. The protection is demonstrated on the oil, and the extension to membrane protection in people is mechanistic.

When tocopherol quenches a lipid radical it becomes a tocopheroxyl radical itself and stops working. Ascorbate at the membrane surface donates an electron to restore it, which is what makes a small amount of vitamin E go a long way. This is the classic antioxidant network and it is settled biochemistry.

EPA and DHA are polyunsaturated fatty acids, so combining a general PUFA source with a marine oil adds to the same class rather than acting separately. What differs is chain length and double bond position, which determine whether the fatty acid ends up as a membrane structural component or a signalling precursor. Total intake and the n-6 to n-3 ratio are what matter.

Delta-6 desaturase is the shared rate-limiting enzyme for converting both the n-6 and n-3 parent fatty acids into their long-chain products. A high linoleic acid intake occupies that enzyme and reduces conversion of alpha-linolenic acid to EPA. This is why the ratio between the two families, not just the absolute amount of either, shapes the outcome.

The delta-5 and delta-6 desaturases that elongate dietary PUFA into their long-chain forms require FAD, built from riboflavin, and cytochrome b5 reductase in the same system. Low riboflavin status slows the conversion. It is a cofactor relationship, so it matters at deficiency rather than as a way to push conversion higher.

Zinc depletion reduces delta-6 desaturase activity, and the resulting shift in fatty acid pattern is one of the recognised biochemical signatures of low zinc status. The knock-on effect is less conversion of dietary parent fatty acids into their long-chain forms. Relevant at deficiency, not above sufficiency.

PUFA absorption depends on bile acid mediated micelle formation, which is triggered by fat reaching the duodenum. Taking a fish oil capsule on an empty stomach gives measurably lower uptake than taking it with a fat-containing meal. Any dietary fat does this, and medium-chain triglycerides are absorbed by a different route themselves.

Without adequate bile the lipid phase stays as large droplets with too little surface area for pancreatic lipase to work on, and fat-soluble material passes through. Anyone who has had their gallbladder removed or has reduced bile output absorbs less from a PUFA oil for this reason. Supplemental bile acids are used clinically in that setting.

Triglycerides are not absorbed intact. Lipase cuts the outer two fatty acids off the glycerol backbone, leaving a 2-monoglyceride and two free fatty acids that enter the micelle. Reduced lipase output directly reduces how much of a PUFA oil is taken up.

High-dose long-chain PUFA reduces platelet aggregation through changes in eicosanoid balance, and nattokinase acts on fibrin. Stacking the two means two independent nudges in the same direction. Anyone on anticoagulant or antiplatelet medication should discuss the combination with whoever prescribes it before starting.

Garlic constituents have their own modest antiplatelet activity, which sits alongside the platelet effect of high-dose long-chain PUFA. Neither alone is dramatic. The point is that additive effects on clotting are worth flagging rather than assuming they cancel out.

Reduced CoQ10 acts as a lipid-phase antioxidant in its own right and also regenerates tocopherol from the tocopheroxyl radical. In a PUFA-rich membrane that adds a second recycling route alongside ascorbate. CoQ10 also needs dietary fat for absorption, so the two are commonly taken together for practical reasons.

Vitamin D is absorbed through the same bile-dependent micellar route as dietary fatty acids, so taking it alongside a PUFA oil raises uptake relative to taking it with a fat-free meal. This is about absorption logistics, not a functional interaction between the two.

Omega-3 PUFA and beta-hydroxy-beta-methylbutyrate were assessed together for functional and metabolic effects, on the reasoning that one addresses membrane and signalling and the other addresses protein turnover. The combination logic is plausible and the human evidence is limited. Read the pairing as investigational.